‘89 sites, health workers to be vaccinated first’: Delhi gears up for COVID vaccination drive

0

Representational Image

HIGHLIGHTS

  • Delhi Health Minister Satyendra Jain on Sunday said that 89 sites, including 36 government and 53 private hospitals have been finalised for the first phase of the COVID-19 vaccination drive.
  • Jain further said that only healthcare workers will be administered vaccine against COVID-19 in the first phase.
  • “In Delhi, 89 sites have been finalised for the first phase of COVID-19 vaccination drive. Govt has identified 36 government and 53 private hospitals for vaccination drive from January 16. In the first phase, only health workers will be vaccinated,” Jain said.
  • The Delhi government recently announced the coronavirus vaccine, whenever it is available, will be provided free of cost to people in the national capital.
  • ‘The Delhi government is fully prepared to receive, store and administer COVID-19 vaccine to 51 lakh priority category persons in the city in the first phase of vaccination. The vaccine will be provided free to everyone on Delhi,’ Health Minister Satyendra Jain had said last week.
  • On Saturday, Delhi Chief Minister Arvind Kejriwal urged the Centre to provide COVID-19 vaccine free to everyone.
  • “Coronavirus is the century’s biggest pandemic. It is important to protect our people from it. I appeal to the Central government to ensure that everyone gets free vaccine. The expenditure on this will save lots of lives,” Kejriwal tweeted in Hindi.
COVID vaccination drive from Jan 16
The COVID-19 vaccination drive will begin across the country from January 16 with priority to be given to nearly three crore healthcare and frontline workers.
The decision was taken on Saturday at a high-level meeting where Prime Minister Narendra Modi reviewed the status of COVID-19 and vaccine preparedness across states and Union territories.
After healthcare and frontline workers, priority will be given to those above 50 years of age and the under-50 population groups with co-morbidities, together numbering around 27 crore, a government statement said.
Last week, India’s drugs regulator gave its nod to two vaccines for coronavirus — manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech, for restricted emergency use in the country.

LEAVE A REPLY

Please enter your comment!
Please enter your name here